GI
KNSA icon

GAMMA Investing’s Kiniksa Pharmaceuticals KNSA Stock Holding History

GAMMA Investing’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$95.4K Buy
1,278
+223
+21% +$16.4K ﹤0.01% 1911
2026
Q2 		$67.5K Buy
1,055
+3
+0.3% +$156 ﹤0.01% 2101
2026
Q1 		$50.7K Sell
1,052
-16
-1% -$709 ﹤0.01% 2170
2025
Q4 		$44.1K Sell
1,068
-58
-5% -$2.33K ﹤0.01% 2152
2025
Q3 		$43.7K Buy
1,126
+150
+15% +$4.87K ﹤0.01% 2087
2025
Q2 		$27K Sell
976
-262
-21% -$6.67K ﹤0.01% 2304
2025
Q1 		$27.5K Buy
1,238
+568
+85% +$11.7K ﹤0.01% 2204
2024
Q4 		$13.3K Sell
670
-171
-20% -$3.9K ﹤0.01% 2466
2024
Q3 		$21K Buy
841
+58
+7% +$1.41K ﹤0.01% 2075
2024
Q2 		$14.6K Sell
783
-71
-8% -$1.33K ﹤0.01% 2048
2024
Q1 		$16.8K Buy
854
+73
+9% +$1.43K ﹤0.01% 1762
2023
Q4 		$13.8K Buy
+781
New +$12.8K ﹤0.01% 1718

Other funds holding KNSA

TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
JWS
Juncture Wealth Strategies Scottsdale, Arizona $390M AUM 19.15% 1-Year Est. Return
CCAL
City Center Advisors LLC Troy, Michigan $131M AUM 24.02% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

GAMMA Investing's KNSA Position: Q3 2026 in Review

GAMMA Investing increased its Kiniksa Pharmaceuticals (KNSA) stake by 21% in Q3 2026, buying an estimated $16.4K and bringing the position to 1,278 shares worth $95.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1911.

GAMMA Investing first reported a position in KNSA in Q4 2023 and has held it in 12 quarters since. 8 funds tracked by Wall St. Rank hold KNSA as of Q3 2026.

  • GAMMA Investing held 1,278 shares of Kiniksa Pharmaceuticals worth $95.4K as of Q3 2026.
  • GAMMA Investing bought 223 Kiniksa Pharmaceuticals shares in Q3 2026, an estimated $16.4K.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #1911 holding.
  • GAMMA Investing first reported a position in Kiniksa Pharmaceuticals in Q4 2023 and has held it in 12 quarters since.
  • 8 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.